FRA:VME (Germany)
Â
Registered Shares
€
5.6
-0.050 (-0.9%)
Sep 21
Business Description
Viromed Medical AG
SIC : 8099
ISIN : DE000A40ZVN7
Share Class Description:
FRA:VME: Registered SharesTotal Employee Number:
17Description
Viromed Medical AG is a German medical technology company that develops and markets cold atmospheric plasma (CAP) devices for medical and hygiene applications. Its product portfolio includes ViroCAP, a medical device that uses cold plasma to treat acute and chronic wounds, and ViroCAP derma-podo, a device for dermatological and podiatric skin and foot care. The company also offers air purification equipment based on plasma technology. Viromed serves healthcare professionals such as physicians, wound care specialists, podiatrists, and clinics, primarily in Germany and other European markets, and it covers the value chain from research and development through production, logistics, marketing, and sales. Revenue is generated mainly through the sale of its medical devices and related consumables, with additional income from distribution partnerships. The company is listed on the German stock exchange.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 40.44 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 19.15 | |||||
Beneish M-Score | 0.85 | |||||
WACC vs ROIC | ||||||
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.99 | |||||
9-Day RSI | 42.49 | |||||
14-Day RSI | 38.39 | |||||
3-1 Month Momentum % | 3.65 | |||||
6-1 Month Momentum % | 19.33 | |||||
12-1 Month Momentum % | 82.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.74 | |||||
Quick Ratio | 2.39 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 70.93 | |||||
Days Sales Outstanding | 36.16 | |||||
Days Payable | 115.59 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 44.92 | |||||
Operating Margin % | -16.95 | |||||
Net Margin % | 11.89 | |||||
EBITDA Margin % | -10.5 | |||||
ROE % | 4.51 | |||||
ROA % | 3.73 | |||||
ROIC % | -5.82 | |||||
ROC (Joel Greenblatt) % | -9.76 | |||||
ROCE % | -3.74 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 196.43 | |||||
PE Ratio without NRI | 196.43 | |||||
PS Ratio | 23.01 | |||||
PB Ratio | 11.15 | |||||
Price-to-Tangible-Book | 15.14 | |||||
EV-to-EBIT | -218.2 | |||||
EV-to-EBITDA | -218.2 | |||||
EV-to-Revenue | 22.91 | |||||
Price-to-Graham-Number | 11.67 | |||||
| Price-to-Net-Current-Asset-Value | 50.91 | |||||
Earnings Yield (Greenblatt) % | -0.46 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Viromed Medical AG Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 5.087 | ||
| EPS (TTM) (€) | 0.029 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 92.86 | ||
| 14-Day RSI | 38.39 | ||
| 14-Day ATR (€) | 0.223313 | ||
| 20-Day SMA (€) | 5.87 | ||
| 12-1 Month Momentum % | 82.05 | ||
| 52-Week Range (€) | 3 - 8.3 | ||
| Shares Outstanding (Mil) | 21.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Viromed Medical AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Viromed Medical AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Viromed Medical AG Frequently Asked Questions
What is Viromed Medical AG(FRA:VME)'s stock price today?
The current price of FRA:VME is €5.60. The 52 week high of FRA:VME is €8.30 and 52 week low is €3.00.
When is next earnings date of Viromed Medical AG(FRA:VME)?
The next earnings date of Viromed Medical AG(FRA:VME) is .
Does Viromed Medical AG(FRA:VME) pay dividends? If so, how much?
Viromed Medical AG(FRA:VME) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers